Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CTLA4 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CTLA4 in ELISA und in vivo. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7543361

Kurzübersicht für Rekombinanter CTLA4 Antikörper (ABIN7543361)

Target

Alle CTLA4 Antikörper anzeigen
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 152
  • 84
  • 45
  • 14
  • 3
Human

Wirt

  • 90
  • 80
  • 22
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Maus

Klonalität

  • 129
  • 72
  • 3
Monoklonal

Konjugat

  • 108
  • 18
  • 13
  • 11
  • 9
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CTLA4 Antikörper ist unkonjugiert

Applikation

  • 97
  • 91
  • 62
  • 59
  • 45
  • 36
  • 19
  • 13
  • 10
  • 7
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
ELISA, In vivo Studies (in vivo)

Klon

5E3
  • Verwendungszweck

    Anti-CTLA-4 [5E3], Mouse IgG1, kappa

    Spezifität

    The antibody is specific for CTLA-4. CTLA-4 is a protein receptor that functions as an immune checkpoint and downregulates immune responses.

    Produktmerkmale

    Original Species of Ab: Mouse

    Original Format of Ab: IgG1

    Aufreinigung

    Protein A affinity purified

    Immunogen

    The original antibody was generated by immunizing BALB/c mice with CTLA-4 protein.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    The specificity of the antibody was confirmed by ELISA analysis. The kinetic parameters of human CTLA-4 protein binding to the antibody were measured and they resulted to be at the sub-nm level. The antitumor activity of the humanized antibody was demonstrated in vivo in animal models. It was proved that the antibody inhibited the tumor in a dose-dependent manner. Mouse PD-1 antibody was combined with the antibody and used to evaluate the toxicity to mice, these experiments compared with the use of Ipilimumab in combination with PD-1 antibody. Results showed that after 5E3 antibody was used in combination with PD-1 antibody, the immunity to the body and the toxicity of heart, liver and lung are significantly lower than the toxicity of Ipilimumab in combination with PD-1 antibody (CN110343180).

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Andere Bezeichnung

    CTLA-4

    Hintergrund

    Cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, CD152

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!